Dr STUART SMITH stuart.smith@nottingham.ac.uk
CLINICAL ASSOCIATE PROFESSOR
CD105 (Endoglin) exerts prognostic effects via its role
in the microvascular niche of paediatric high grade glioma
Smith, Stuart J.; Tilly, Hanna; Ward, Jennifer H.; Macarthur, Donald C.; Lowe, James; Coyle, Beth; Grundy, Richard G.
Authors
Hanna Tilly
Jennifer H. Ward
Donald C. Macarthur
James Lowe
Professor BETH COYLE BETH.COYLE@NOTTINGHAM.AC.UK
PROFESSOR OF BRAIN TUMOUR MICROENVIRONMENT
Richard G. Grundy
Abstract
Paediatric high grade glioma (pHGG) (World Health Organisation astrocytoma grades III and IV) remains poor prognosis tumours, with a median survival of only 15 months following diagnosis. Current investigation of anti-angiogenic strategies has focused on adult glioblastoma multiforme (GBM) with phase III trials targeting vascular endothelial growth factor continuing. In this study we investigated whether the degree of vascularity correlated with prognosis in a large cohort of pHGG (n = 150) and whether different vessel markers carried different prognostic value. We found that CD105 (endoglin) had a strongly significant association with poor prognosis on multivariate analysis (p = <0.001). Supervised hierarchical clustering of genome wide gene expression data identified 13 genes associated with differential degrees of vascularity in the cohort. The novel angiogenesis-associated genes identified in this analysis (including MIPOL-1 and ENPP5) were validated by realtime polymerase chain reaction. We also demonstrate that CD105 positive blood vessels associate with CD133 positive tumour cells and that a proportion of CD105 positive vessel cells demonstrates co-positivity for CD133, suggesting that the recently described phenomenon of vasculogenic mimicry occurs in pHGG. Together, the data suggest that targeting angiogenesis, and in particular CD105, is a valid therapeutic strategy for pHGG.
Citation
in the microvascular niche of paediatric high grade glioma. Acta Neuropathologica, 124(1), https://doi.org/10.1007/s00401-012-0952-1
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 29, 2012 |
Online Publication Date | Feb 7, 2012 |
Publication Date | Jul 1, 2012 |
Deposit Date | Mar 25, 2014 |
Publicly Available Date | Mar 25, 2014 |
Journal | Acta Neuropathologica |
Print ISSN | 0001-6322 |
Electronic ISSN | 1432-0533 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 124 |
Issue | 1 |
DOI | https://doi.org/10.1007/s00401-012-0952-1 |
Keywords | Glioblastoma, Angiogenesis, Endoglin, CD133 |
Public URL | https://nottingham-repository.worktribe.com/output/1007243 |
Publisher URL | http://link.springer.com/article/10.1007/s00401-012-0952-1 |
Contract Date | Mar 25, 2014 |
Files
GrundyCD105.pdf
(700 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies
(2023)
Journal Article
Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search